Additive antitumour effect of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib (Iressa, ZD1839) and the antioestrogen fulvestrant (Faslodex, ICI 182,780) in breast cancer cells

Growth Factor ◽

Epidermal Growth Factor ◽

Breast Cancer Cells ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Antitumour Effect ◽

Evaluation of Biologic End Points and Pharmacokinetics in Patients With Metastatic Breast Cancer After Treatment With Erlotinib, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor

Breast Diseases A Year Book Quarterly ◽

10.1016/s1043-321x(05)80054-2 ◽

2005 ◽

Vol 16 (1) ◽

pp. 66

Author(s):

B. Rubio-Viqueira ◽

M. Hidalgo

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Reverses Mesenchymal to Epithelial Phenotype and Inhibits Metastasis in Inflammatory Breast Cancer

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-09-0951 ◽

2009 ◽

Vol 15 (21) ◽

pp. 6639-6648 ◽

Cited By ~ 74

Author(s):

D. Zhang ◽

T. A. LaFortune ◽

S. Krishnamurthy ◽

F. J. Esteva ◽

M. Cristofanilli ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Inflammatory Breast Cancer ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Epithelial Phenotype ◽

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor

10.32388/jfobd7 ◽

2020 ◽

Author(s):

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Receptor Tyrosine Kinase Inhibitor ◽

Association between E-cadherin and sensitivity of hepatocellular carcinoma to treatment with epidermal growth factor receptor tyrosine kinase inhibitor

Academic Journal of Second Military Medical University ◽

10.3724/sp.j.1008.2014.00915 ◽

2014 ◽

Vol 35 (8) ◽

pp. 915

Author(s):

Rong-chun XING ◽

Jun ZHENG ◽

Ping CHEN ◽

Wei-hong ZHENG ◽

Wei LIU ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Glucose metabolism-targeted therapy and withaferin A are effective for epidermal growth factor receptor tyrosine kinase inhibitor-induced drug-tolerant persisters

Cancer Science ◽

10.1111/cas.13266 ◽

2017 ◽

Vol 108 (7) ◽

pp. 1368-1377 ◽

Cited By ~ 4

Author(s):

Kei Kunimasa ◽

Tatsuya Nagano ◽

Yohei Shimono ◽

Ryota Dokuni ◽

Tatsunori Kiriu ◽

...

Keyword(s):

Targeted Therapy ◽

Growth Factor ◽

Glucose Metabolism ◽

Epidermal Growth Factor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Withaferin A ◽

Downregulation of the antiapoptotic MCL-1 protein and apoptosis in MA-11 breast cancer cells induced by an anti-epidermal growth factor receptor-Pseudomonas exotoxin a immunotoxin

International Journal of Cancer ◽

10.1002/ijc.20371 ◽

2004 ◽

Vol 112 (3) ◽

pp. 475-483 ◽

Cited By ~ 47

Author(s):

Yvonne Andersson ◽

Siri Juell ◽

�ystein Fodstad

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Cancer Cells ◽

Breast Cancer Cells ◽

Growth Factor Receptor ◽

Pseudomonas Exotoxin ◽

Pseudomonas Exotoxin A ◽

A report of two bronchioloalveolar carcinoma cases which were rapidly improved by treatment with the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 ("Iressa"1

Cancer Science ◽

10.1111/j.1349-7006.2003.tb01464.x ◽

2003 ◽

Vol 94 (5) ◽

pp. 453-458 ◽

Cited By ~ 36

Author(s):

Seiji Yano ◽

Takanori Kanematsu ◽

Toyokazu Miki ◽

Yoshinori Aono ◽

Masahiko Azuma ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Bronchioloalveolar Carcinoma ◽

Abstract 419: Presence of pulmonary tuberculosis impair survival in advancedEGFRmutation lung adenocarcinoma patients receiving epidermal growth factor receptor-tyrosine kinase inhibitor

10.1158/1538-7445.am2021-419 ◽

2021 ◽

Author(s):

Yalin Xie ◽

Wei Zhou ◽

An Lei ◽

Zhan Huang ◽

Li Weiwei ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Pulmonary Tuberculosis ◽

Lung Adenocarcinoma ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Effects of CDK4/6 Inhibition in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Cells with Acquired Resistance to Paclitaxel

Journal of Cancer ◽

10.7150/jca.14441 ◽

2016 ◽

Vol 7 (8) ◽

pp. 947-956 ◽

Cited By ~ 4

Author(s):

Adriana Priscila Trapé ◽

Shuying Liu ◽

Andrea Carolina Cortes ◽

Naoto T. Ueno ◽

Ana Maria Gonzalez-Angulo

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Cancer Cells ◽

Breast Cancer Cells ◽

Acquired Resistance ◽

Growth Factor Receptor ◽

Hormone Receptor Positive ◽

Enhanced Sensitivity to the HER1/Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib Hydrochloride in Chemotherapy-Resistant Tumor Cell Lines

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-04-0993 ◽

2005 ◽

Vol 11 (4) ◽

pp. 1572-1578 ◽

Cited By ~ 59

Author(s):

Qun Dai ◽

Yi-He Ling ◽

Marie Lia ◽

Yi-Yu Zou ◽

Glenn Kroog ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Tumor Cell ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Tumor Cell Lines ◽

Enhanced Sensitivity ◽